Artissue
Artissue Inc. is pioneering regenerative medicine with a focus on creating a sustainable society and improving the well-being of future generations. They are developing an AI-based fully automated cell manufacturing system to streamline the regenerative medicine value chain, aiming to significantly reduce manufacturing costs. Their vision is to be the sole company capable of recovering health both mentally and physically, offering a unique approach that interweaves emotional well-being, freedom, and open-mindedness for patients with unmet medical needs. The company targets the substantial regenerative medicine market, projected to reach $180B by 2030, and emphasizes its unique position as a design-focused company in this sector.
Artissue
Artissue Inc. is pioneering regenerative medicine with a focus on creating a sustainable society and improving the well-being of future generations. They are developing an AI-based fully automated cell manufacturing system to streamline the regenerative medicine value chain, aiming to significantly reduce manufacturing costs. Their vision is to be the sole company capable of recovering health both mentally and physically, offering a unique approach that interweaves emotional well-being, freedom, and open-mindedness for patients with unmet medical needs. The company targets the substantial regenerative medicine market, projected to reach $180B by 2030, and emphasizes its unique position as a design-focused company in this sector.